Scandinavian journal of medicine & science in sports · 2025
Effect of Low-Load Blood-Flow Restricted Training Versus Heavy Slow Resistance Training in Unilateral Patellar Tendinopathy: A Randomized Clinical Trial.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hjortshoej Mikkel Holm, Juneja Hemant, Svensson René Brüggebusch, Herzog Robert Bennike, Lundgaard-Nielsen Mathilde, Nielsen Frederik Kronvold, Wulff Mette With, Olsen Amanda Emilie, Nybing Janus Damm, Hansen Philip, Petersen Jesper, Kjaer Michael, Aagaard Per, Magnusson Stig Peter, Couppé Christian
Аннотация
Patellar tendinopathy (PT) is a debilitating overuse injury, and one of the current recommended treatments is heavy slow resistance training (HSRT); Recently, low-load resistance training combined with blood flow restriction (LL-BFRT) has been advocated as a clinically relevant rehabilitation tool for PT since it does not involve large joint and tissue stresses and may accelerate recovery. This study aimed to investigate the effect of LL-BFRT compared with HSRT at 3, 6, 12 (primary endpoint), and 52 weeks. Participants with chronic unilateral PT were randomized to a 12-week rehabilitation program based on either LL-BFRT (n = 16) or HSRT (n = 20). The primary outcome was pain (numerical rating scale (NRS) 0-10) during a single-leg decline squat (SLDS). Secondary outcome variables included the Victorian Institute of Sports Assessment-Patella questionnaire (VISA-P), maximal isometric knee extensor strength, patellar tendon morphology assessed by ultrasonography (swelling, vascularization), and magnetic resonance imaging (MRI). Comparable clinically relevant improvements in pain (NRS during SLDS, least squares mean ± SEM) were observed in LL-BFRT (LL-BFRT: 0 weeks 3.9 ± 0.5, 12 weeks 2.2 ± 0.5, 52 weeks 1.8 ± 0.5) and HSRT (0 weeks 4.2 ± 0.4, 12 weeks 2.2 ± 0.4, 52 weeks 1.1 ± 0.5) (p < 0.0001). Likewise, clinically relevant improvements were reported on the VISA-P score. LL-BFRT and HSRT resulted in comparable short-term and long-term clinical improvements in males with chronic PT. These data advocate that LL-BFRT represents an effective rehabilitation tool in the treatment of chronic PT, while preventing high joint and tendon loads. Trial Registration: Clinicaltrials.org (NCT04550013).